Listen "Immuno-oncology biomarkers in locally advanced HNSCC - lessons from the KeyNote-689 trial - report from ESMO 2025"
Episode Synopsis
Professor Cécile Badoual shares her thoughts on the immuno-oncology biomarkers in locally advanced HNSCC and explains the lessons from the KeyNote-689 trial after the ESMO Congress 2025.Video: https://medicaldigest.org/scientific-contents/interview:immuno-oncology-biomarkers-locally-advanced-hnscc-lessons-keynote-689-trial
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.